ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA

Anti-angiogenic therapy of glioblastoma with bevacizumab, a vascular endothelial growth factor-A (VEGFA) blocking antibody, may accelerate tumor cell invasion and induce alternative angiogenic pathways. We investigated the roles of the pro-angiogenic receptor APLNR and its cognate ligand apelin in V...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Kälin, Roland, Mastrella, Giorgia, Hou, Mengzhuo, Li, Min, Stoecklein, Veit, Zdouc, Nina, Volmar, Marie, Miletic, Hrvoje, Reinhard, Sören, Herold-Mende, Christel, Kleber, Susanne, Eisenhut, Katharina, Gargiulo, Gaetano, Synowitz, Michael, Vescovi, Angelo, Harter, Patrick, Penninger, Josef, Wagner, Ernst, Mittelbronn, Michel, Bjerkvig, Rolf, Hambardzumyan, Dolores, Schüller, Ulrich, Tonn, Joerg-Christian, Radke, Josefine, Glass, Rainer
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Angiogenesis and Invasion
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847580/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.114
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items